TerminatedPhase 1NCT06215755
A Study of VRG50635 in Participants With Amyotrophic Lateral Sclerosis (ALS)
Studying Amyotrophic lateral sclerosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Verge Genomics
- Principal Investigator
- Diego Cadavid, MDVerge Genomics
- Intervention
- VRG50635(drug)
- Enrollment
- 54 enrolled
- Eligibility
- 18-74 years · All sexes
- Timeline
- 2024 – 2025
Study locations (7)
- UZ Leuven, Leuven, Flemish Brabant, Belgium
- Stan Cassidy Centre for Rehabilitation (Horizon NB), Montreal, Quebec, Canada
- The Neuro - Montréal Neurological Institute-Hospital, Montreal, Quebec, Canada
- University of Eastern Finland, Brain Research Unit, Kuopio, Eastern Finland, Finland
- Helsinki University Hospital, Helsinki, Uusimaa, Finland
- Turku University Hospital, Turku, Western Finland, Finland
- University Medical Center Utrecht, Utrecht, Netherlands
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06215755 on ClinicalTrials.govOther trials for Amyotrophic lateral sclerosis
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07401186Stimulation-Based Modulation of Spinal and Cortical Sensory PathwaysPeter C. Gerszten, MD
- RECRUITINGNCT07467187Invasive Home Ventilation in DenmarkRigshospitalet, Denmark
- RECRUITINGNCT07259980A Study to Learn More About the Long-Term Safety of Tofersen (Qalsody) in Participants With Superoxide Dismutase 1 (SOD-1) Amyotrophic Lateral Sclerosis (ALS)Biogen
- RECRUITINGNCT07502677Diagnostic Accuracy of SleepImage Technology for Detecting Respiratory Failure in Patients With Amyotrophic Lateral SclerosisRoyal Brompton & Harefield NHS Foundation Trust
- RECRUITINGNANCT07446114Functional Outcomes and Control Using Synchron BCI - CanadaSynchron, Inc.
- ENROLLING BY INVITATIONPHASE2, PHASE3NCT07410806HEALEY ALS Platform Trial - Regimen I NUZ-001Merit E. Cudkowicz, MD
- ENROLLING BY INVITATIONNANCT07298486Impact of Robotic Glove Use on Quality of Life, Grip Strength and Fine Motor Control in ALSNova Southeastern University
- ACTIVE NOT RECRUITINGPHASE1NCT07204977Acamprosate in C9orf72 Hexanucleotide Repeat Expansion Amyotrophic Lateral Sclerosis (ACALS)National Institute of Neurological Disorders and Stroke (NINDS)